未登录

R

Ruoying Yu

geneseeq technology inc.

H指数:18

被引数:1,078

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Physics-Embedded Graph Convolutional Network with Topology-Adaptive Transfer Learning for Power Flow Prediction

嵌入物理学的拓扑自适应迁移学习图卷积网络用于潮流预测

IEEE Transactions on Smart Grid

IF9.8

2026-08-040

PRE

Clinical value of FAT1 mutations to indicate the immune response in colorectal cancer patients

IF3

2024-03-012

OAAI

Multi-timescale risk scheduling for transmission and distribution networks for highly proportional distributed energy access

INTERNATIONAL JOURNAL OF ELECTRICAL POWER & ENERGY SYSTEMS

IF5

2024-01-013

OAAI

Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2023-02-0110

PRE

Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups

FRONTIERS IN ONCOLOGY

IF3.3

2022-11-104

OAAI

Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer

MOLECULAR ONCOLOGY

IF4.5

2022-08-157

OA

Clinical implications of EGFR-associated MAPK/ERK pathway in multiple primary lung cancer

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2022-05-1110

OAAI

Altered Signaling Pathways Revealed by Comprehensive Genomic Profiling in Patients With Unknown Primary Tumors

FRONTIERS IN ONCOLOGY

IF3.3

2022-03-243

OAAI

Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets

CLINICAL LUNG CANCER

IF3.3

2022-03-0112

PRE

Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2022-02-054

OAAI

Real-world circulating tumor DNA analysis depicts resistance mechanism and clonal evolution in ALK inhibitor-treated lung adenocarcinoma patients

IF8.3

2022-02-0123

OAAI

Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-2510

OAAI

A Case of Lung Adenocarcinoma Harboring a Rare LOC285000-ALK-NCK2 Gene Fusion Identified by Next-Generation Sequencing With Long-Term Response to Crizotinib

JTO CLINICAL AND RESEARCH REPORTS

IF3.5

2021-02-011

OAAI

Association of circulating tumor DNA from the cerebrospinal fluid with high-risk CNS involvement in patients with diffuse large B-cell lymphoma

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2021-01-159

OAAI

Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2-targeted therapies

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2020-12-1531

OAAI

Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2020-11-2428

OAAI

Clonal heterogeneity and evolution of multifocal lung cancers revealed by whole exome sequencing to facilitate molecular diagnosis of multiple primary lung cancers

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Clinical and molecular characteristics of Chinese non-small cell lung cancer patients with ERBB2 transmembrane domain mutations

MOLECULAR ONCOLOGY

IF4.5

2020-07-015

OAAI

Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors

JOURNAL OF MEDICAL GENETICS

IF3.7

2020-04-139

PREAI

Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2020-01-19138

OAAI